Recent advances in bone biology provide insight into the pathogenesis of bone diseases

Laboratory Investigation

Volumn 79, Issue 2, 1999, Pages 83-94

  Boyce, Brendan F ^a   Hughes, David E ^b   Wright, Kenneth R ^c   Xing, Lianping ^a   Dai, Aihua ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b CHESTERFIELD ROYAL HOSPITAL   (United Kingdom)

^c LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE; ARACHIDONATE 5 LIPOXYGENASE; BISPHOSPHONIC ACID DERIVATIVE; COLONY STIMULATING FACTOR 1; ESTROGEN; FIBROBLAST GROWTH FACTOR RECEPTOR; GENE PRODUCT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OSTEOCALCIN; PARATHYROID HORMONE RELATED PROTEIN; PROTEIN C FOS; SIALOPROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

BONE ATROPHY; BONE CELL; BONE DISEASE; BONE REMODELING; CALCIUM HOMEOSTASIS; GENE EXPRESSION; HUMAN; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW;

ANIMALS; BONE AND BONES; BONE DEVELOPMENT; BONE DISEASES; BONE REMODELING; MICE; PHYSIOLOGY;

EID: 0032985446     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (113)

1. Amling M, Neff L, Tanaka S, Inoue D, Kuida K, Weir E, Philbrick WM, Broadus AE, and Baron R (1997). Bcl-2 lies downstream of parathyroid hormone-related peptide in a signaling pathway that regulates chondrocyte maturation during skeletal development. J Cell Biol 136:205-213.
2. Anderson DM, Maraskovsky E, Billingsley WL, Dougall WC, Tometsko ME, Roux ER, Teepe MC, DuBose RF, Cosman D, and Galibert L (1997). A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390:175-179.
3. Arnett TR, Lindsay R, Kilb JM, Moonga BS, Spowage M, and Dempster DW (1996). Selective toxic effects of tamoxifen on osteoclasts: comparison with the effects of oestrogen. J Endocrinol 149:503-508.
4. Aubin JE, Gupta AK, Zirngbl R, and Rossant J (1996). Knockout mice lacking bone sialoprotein expression have bone abnormalities (Abstract). J Bone Miner Res 11:S102.
5. Bell D, Leung K, Wheatley S, Ng LJ, Zhou S, Ling K, Sham M, Koopman P, Tam P and Cheah K (1997). SOX9 directly regulates the type-II collagen gene. Nat Genet 16:174-178.
6. Bellido T, Jilka RL, Boyce BF, Girasole G, Broxmeyer H, Dalrymple SA, Murray R, and Manolagas SC (1995). Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. J Clin Invest 95:2886-2895.
7. c-src expression for osteoclasts to form ruffled borders and resorb bone in mice. J Clin Invest 90:1622-1627.
8. Bronckers ALJJ, Goei W, Luo G, Karsenty G, D'Souza RN, Lyaruu DM, and Burger EH (1996). DNA fragmentation during bone formation in neonatal rodents assessed by transferase-mediated end labeling. J Bone Miner Res 11:1281-1291.
9. Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, and Simonet WS (1998). Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12:1260-1268.
10. Burnet L, McMahon J, McMahon A, and Harland R (1998). Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. Science 280:1455-1457.
11. Bushdid PB, Brantley DM, Yull FE, Blaeuer GL, Hoffman LH, Niswander L, and Kerr LD (1998). Inhibition of NF-κB activity results in disruption of the apical ectodermal ridge and aberrant limb morphogenesis. Nature 392:615-618.
12. Charite J, deGraaff W, Shen S, and Deschamps J (1994). Ectopic expression of Hoxb8 causes duplication of the ZPA in the forelimb and homeotic transformation of axial structures. Cell 78:589-601.
13. Chiang C, Litingtung Y, Lee E, Young K, Corden J, Westphal H, and Beachy P (1996). Cyclopia and defective axial patterning in mice lacking. Nature 383:407-413.
14. Damoulis PD and Hauschka PV (1997). Nitric oxide acts in conjunction with proinflammatory cytokines to promote cell death in osteoblasts. J Bone Miner Res 12:412-422.
15. Ducy P and Karsenty G (1995). Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol Cell Biol 15:1858-1869.
16. Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C, Smith E, Bonadio J, Goldstein S, Gundberg C, Bradley A, and Karsenty G (1996). Increased bone formation in osteocalcin-deficient mice. Nature 382:448-452.
17. Ducy P, Zhang R, Geoffroy V, Ridall AL, and Karsenty G (1997). Osf2/Cbfa 1: A transcriptional activator of osteoblast differentiation. Cell 89:747-754.
18. Dunstan CR, Evans RA, Hills E, Wong SY, and Higgs RJ (1990). Bone death in hip fracture in the elderly. Calcif Tissue Int 47:270-275.
19. Dunstan CR, Somers NM, and Evans RA (1993). Osteocyte death and hip fracture. Calcif Tissue Int 53:S113-S116.
20. Duprez D, Bell E, Richardson M, Archer C, Wolpert L, Brickell P, and Francis-West P (1996). Overexpression of BMP-2 and BMP-4 alters the size and shape of developing skeletal elements in the chick limb. Mech Dev 57:145-157.
21. el Ghouzzi V, Le Merrer M, Perrin-Schmitt F, Lajeunie E, Benit P, Renier D, Bourgeois P, Bolcato-Bellemin AL, Munnich A, Bonaventure J (1997). Mutations of the TWIST gene in the Saethre-Chotzen syndrome. Nat Genet 15:42-46.
22. Elmardi AS, Katchburian MV, and Katchburian E (1990). Electron microscopy of developing calvaria reveals images that suggest that osteoclasts engulf and destroy osteocytes during bone resorption. Calcif Tissue Int 46:239-245.
23. Flynn MA, Qiao M, Dallas M, Mundy GR, Boyce BF, and Bonewald LF (1996). Mice lacking the gene for 5-lipoxygenase have increased cortical bone thickness (Abstract). J Bone Miner Res 11:S108.
24. Foster J, Dominguez-Steglich M, Guioli S, Kowk G, Weller P, Stevanovic M, Weissenbach J, Mansour S, Young I, and Goodfellow P (1994). Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 372:525-530.
25. Franzoso G, Carlson L, Xing L, Poljak L, Shores EW, Brown KD, Leonardi A, Tran T, Boyce BF, and Siebenlist U (1997). Requirement for NF-κB in osteoclast and B cell development. Genes Dev 11:3482-3496.
26. Garcia C, Boyce BF, Gilles J, Dallas M, Qiao M, Mundy GR, and Bonewald LF (1996). Leukotriene B4 stimulates osteoclastic bone resorption both in vitro and in vivo. J Bone Miner Res 11:1619-1627.
27. Grigoriadis AE, Wang Z-Q, Cecchini MG, Hofstetter W, Felix R, Fleisch HA, and Wagner EF (1994). c-Fos: A key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266:443-448.
28. Hayman AR, Jones SJ, Boyde A, Foster D, Colledge WH, Carlton MB, Evans MJ, and Cox TM (1996). Mice lacking tartrate-resistant acid phosphatase (Acp5) have disrupted endochondral ossificiation and mild osteopetrosis. Development 122:3151-3162.
29. Henderson JE, Amizuka N, Warshawsky D, Biasotto D, Lanske BMK, Goltzman D, and Karaplis AC (1995). Nucleolar localization of parathyroid hormone-related peptide enhances survival of chondrocytes under conditions that promote apoptotic cell death. Mol Cell Biol 15:4064-4075.
30. Hill PA, Tumber A, and Meikle MC (1997). Multiple extracellular signals promote osteoblast survival and apoptosis. Endocrinology 138:3849-3858.
31. Hodgkinson CA, Moore KJ, Nakayama A, Steingrimsson E, Copeland NG, Jenkins NA, and Arnheiter H (1993). Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell 74:395-404.
32. Hogan BLM (1996). Bone morphogenetic proteins: Multifunctional regulators of vertebrate development. Genes Dev 10: 1580-1594.
33. Horowitz MC (1993). Cytokines and estrogen in bone; anti-osteoporotic effects. Science 260:626-627.
34. Horton WA (1997). Fibroblast growth factor receptor 3 and the human chondrodysplasias. Curr Opin Pediatr 9:437-442.
35. Howard T, Paznekas W, Green E, Chiang L, Ma N, Ortiz de Luna R, Garcia Delgado C, Gonzalez-Ramos M, Kline A, and Jabs E (1997). Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrom. Nat Genet 15:36-41.
36. 1 induces osteoclast apoptosis in vitro (Abstract). J Bone Miner Res 9:S138.
37. Hughes DE, Wright KR, Sasaki A, YonedaT, Uy H, Roodman GD, Mundy GR, and Boyce BF (1994b). Bisphosphonates induce osteoclast apoptosis in vivo and in vitro, but calcitonin does not (Abstract). J Bone Miner Res 9:S347.
38. Hughes DE, Jilka R, Manolagas S, Dallas SL, Bonewald LF, Mundy GR, and Boyce BF (1995a). Sex steroids promote osteoclast apoptosis in vitro and in vivo (Abstract). J Bone Miner Res 10:S150.
39. Hughes DE, Wright KR, Uy HL, Sasaki A, Yoneda T, Roodman GD, Mundy GR, and Boyce BF (1995b). Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res 10:1478-1487.
40. Hughes DE, Dai A, Tiffee JC, Li HH, Mundy GR, and Boyce BF (1996). Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-β. Nature Med 2:1132-1136.
41. Innis J and Mortlock D (1998). Limb development: Molecular dysmorphology is at hand! Clin Genet 53:337-348.
42. Iotsova V, Caamano J, Loy J, Lewin A, and Bravo R (1997). Osteopetrosis in mice lacking NF-κB1 and NF-κB2. Nature Med 3:1285-1289.
43. Jacenko O, Ito S, and Olsen BR (1996). Skeletal and hematopoietic defects in mice transgenic for collagen X. Ann N Y Acad Sci 785:278-280.
44. Jilka RL, Weinstein RS, Bellido T, Parfitt AM, and Manolagas SC (1998). Osteoblast programmed cell death (apoptosis): Modulation by growth factors and cytokines. J Bone Miner Res 13:793-802.
45. Jimi E, Shuto T, and Koga T (1995). Macrophage colony-stimulating factor and interleukin-1α maintain the survival of osteoclast-like cells. Endocrinology 136:808-811.
46. Kanegae Y, Tavares AT, Izpisua-Belmonte JC, and Verma IM (1998). Role of rel/NFκB transcription factors during the outgrowth of the vertebrate limb. Nature 392:611-614.
47. Karaplis AC, Luz A, Glowacki J, Bronson RT, Tybulewicz VL, Kronenberg HM, and Mulligan RC (1994). Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev 8:277-289.
48. Kerr JFR, Wyllie AH, and Currie AR (1972). Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239-257.
49. Kitajima I, Nakajima T, Imamura T, Takasaki I, Kawahara K, Okano T, Tokioka T, Soejima Y, Abeyama K, and Maruyama I (1996). Induction of apoptosis in murine clonal osteoblasts expressed by human T-cell leukemia virus type I tax by NF-κB and TNF-α. J Bone Miner Res 11:200-210.
50. Komori Y, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, and Kishimoto T (1997). Targeted disruption of Cbfa 1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755-764.
51. Kondo T, Zakany J, Innis J, and Duboule D (1997). Of fingers, toes and penises (letter). Nature 390:29.
52. Lanske B, Karaplis AC, Lee K, Luz A, Vortkamp A, Pirro A, Karperien M, Defize LHK, Ho C, Mulligan RC, Abou-Samra AB, Juppner H, Segre GV, and Kronenberg HM (1996). PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science 273:663-666.
53. Lanyon LE (1993). Osteocytes, strain detection, bone modelling and remodelling. Calcif Tissue Int 53:S102-S107.
54. Laufer E, Nelson C, Johnson R, Morgan B, and Tabin C (1994). Sonic hedgehog and Fgf-4 act through a signaling cascade and feedback loop to intetrate growth and paterning of the developing limb bud. Cell 79:993-1003.
55. Lee K, Lanske B, Karaplis AC, Deeds JD, Kohno H, Nissenson RA, Kronenberg HM, and Segre GV (1996). Parathyroid hormone-related peptide delays terminal differentiation of chondrocytes during endochondral bone development. Endocrinology 137:5109-5118.
56. Lewinson D and Silbermann M (1992). Chondroclasts and endothelial cells collaborate in the process of cartilage resorption. Anat Rec 233:504-514.
57. Luckman SP, Hughes DE, Coxon FP, Graham R, Russell G, and Rogers MJ (1998). Nitrogen-containing bisphosphonates inhibit the mevalonte pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras. J Bone Miner Res 13:581-589.
58. Lutton JD, Moonga BS, and Dempster DW (1996). Osteoclast demise in the rat: Physiological versus degenerative cell death. Exp Physiol 81:251-260.
59. Merino R, Ganan Y, Macias D, Economides A, Sampath K, and Hurle J (1998). Morphogenesis of digits in the avian limb is controlled by FGFs, TGFbetas, and noggin through BMP signaling. Dev Biol 200:33-45.
60. Mullender MG, van der Meer DD, Huiskes R, and Lips P (1996). Osteocyte density changes in aging and osteoporosis. Bone 18:109-113.
61. Mundlos S and Olsen B (1997a). Heritable diseases of the skeleton: Part I - Molecular insights into skeletal development-transcription factors and signaling pathways. FASEB J 11:125-132.
62. Mundlos S and Olsen B (1997b). Heritable diseases of the skeleton: Part II - Molecular insights into skeletal development-matrix components and their homeostasis. FASEB J 11:227-233.
63. Mundy GR and Guise TA (1998). Role of PTH-rp in the hypercalcemia of malignancy and osteolytic bone disease. Endocr-Relat Cancer 5:15-26.
64. Muragaki Y, Mundlos S, Upton J, and Olsen B (1996). Altered growth and branching patterns in synpolydactyly caused by mutations in HOXD13. Science 272:548-551.
65. Narisawa S, Frohlander N, and Millan JL (1997). Inactivation of two mouse alkaline phosphatase genes and establishment of a model of infantile hypophosphatasia. Dev Dyn 208:432-446.
66. Nesbitt SA and Horton MA (1997). Trafficking of matrix collagens through bone-resorbing osteoclasts. Science 276: 266-269.
67. Niswander L (1997). Limb mutants: What can they tell us about normal limb development? Curr Opin Gen Dev 7:530-536.
68. Ohuchi H, Nakagawa T, Yamamoto A, Araga A, Ohata T, Ishimaru Y, Yoshioka H, Kuwana T, Nohno T, Yamasaki M, Itoh N, and Noji S (1997). The mesenchymal factor FGF10, initiates and maintains the outgrowth of the chick limb bud through interaction with FGF8, an apical ectodermal factor. Development 124:2235-2244.
69. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GWH, Beddington RSP, Mundlos S, Olsen BR, Selby PB, and Owen MJ (1997). Cbfa 1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89:765-771.
70. Pacifici R (1996). Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 11:1043-1051.
71. Panganiban G, Irvine S, Lowe C, Roehl H, Corley L, Sherbon B, Grenier J, Fallon J, Kimble J, Walker M, Wray G, Swalla B, Martindale M, and Carroll S (1997). The origin and evolution of animal appendages. Proc Natl Acad Sci U S A 94:5162-5166.
72. Parfitt AM (1994). Osteonal and hemi-osteonal remodeling: The spatial and temporal framework for signal traffic in adult human bone. J Cell Biochem 55:273-286.
73. Parfitt AM, Mathews CHE, Villanueva AR, Kleerekoper M, Frame B, and Rao DS (1983). Relationships between surface, volume and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss. J Clin Invest 72:1396-1409.
74. Philbrick WM, Wysolmerski JJ, Galbraith S, Holt E, Orloff JJ, Yang KH, Vasavada RC, Weir EC, Broadus AE, and Stewart AF (1996). Defining the roles of parathyroid hormone-related protein in normal physiology. Physiol Rev 76:127-173.
75. Popoff SN and Marks SC Jr (1995). The heterogeneity of the osteopetroses reflects the diversity of cellular influences during skeletal development. Bone 17:437-445.
76. Rancourt D, Tsuzuki T, and Capecchi M (1995). Genetic interaction between hoxb-5 and hoxb-6 is revealed by non-allelic noncomplementation. Genes Dev 9:108-122.
77. Reed JC (1994). Bcl-2 and the regulation of programmed cell death. J Cell Biol 124:1-6.
78. Riddle R, Johnson R, Laufer E, and Tabin C (1993). Sonic Hedgehog mediates the polarizing activity of the ZPA. Cell 75:1401-1416.
79. Riggs BL, Khosla S, and Melton LJ III (1998). A unitary model for involutional osteoporosis: Estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res 13:763-773.
80. Rittling SR, Matsumoto HN, McKee MD, Nanci A, An XR, Novik KE, Kowalski AJ, Noda M, and Denhardt D (1998). Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro. J Bone Miner Res 13:1101-1111.
81. Roach HI, Erenpreisa J, and Aigner T (1995). Osteogenic differentiation of hypertrophic chondrocytes involves cell divisions and apoptosis. J Cell Biol 131:483-494.
82. Rowe DA and Fallon JF (1982). The proximodistal determination of skeletal parts in the developing chick Jeg. J Embryol Exp Morphol 68:1-7.
83. Salo J, Lehenkari P, Mulari M, Metsikko K, and Vaananen HK (1997). Removal of osteoclast bone resorption products by transcytosis. Science 276:270-273.
84. Satake M, Nomura S, Yamaguchi-lwai Y, Takahama Y, Hashimoto Y, Niki M, Kitamura Y, and Ito Y (1995). Expression of the runt domain-encoding PEBP2α genes in T cells during thymic development. Mol Cell Biol 15:1662-1670.
85. Schipani E, Kruse K, and Juppner H (1995). A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science 268:98-100.
86. Searls RL and Janners MY (1971). The initiation of limb bud outgrowth in the embryonic chick. Dev Biol 24:198-213.
87. Selander KS, Harkonen PL, Valve E, Monkkonen J, Hannuniemi R, and Vaananen HK (1996). Calcitonin promotes osteoclast survival in vitro. Mol Cell Endocrinol 122:119-129.
88. Shubin N, Tabin C, and Carroll S (1997). Fossils, genes and the evolution of animal limbs. Nature 388:639-648.
89. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, and Boyle WJ (1997). Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 89:309-319.
90. Soriano P, Montgomery C, Geske R, and Bradley A (1991). Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64:693-702.
91. Spranger J, Wintrpacht A, and Zabel B (1994). They type II collagenopathies: A spectrum of chondrodysplasias. Eur J Pediatr 153:56-65.
92. Storm E and Kingsley D (1996). Joint patterning defects caused by single and double mutations in members of the bone morphogenetic protein (BMP) family. Development 233: 3969-3979.
93. Strewler GJ, Stern PH, Jacobs JW, Eveloff J, Klein RF, Leung SC, Rosenblatt M, and Nissenson RA (1987). Parathyroid hormone-like protein from human renal carcinoma cells. Structural and functional homology with parathyroid hormone. J Clin Invest 80:1803-1807.
94. Suda T, Nakamura I, Jimi E, and Takahashi N (1997). Regulation of osteoclast function. J Bone Miner Res 12:869-879.
95. Suva LJ, Winslow GA, Wettenhall REH, Hammonds RG, Moseley JM, Diefenbach-Jagger H, Rodda CP, Kemp BE, Rodriguez H, Chen EY, Hudson PJ, Martin TJ, and Wood WI (1987). A parathyroid hormone-related protein implicated in malignant hypercalcemia: Cloning and expression. Science 237:893-896.
96. Thomas JT, Kilpatrick MW, Lin K, Erlacher L, Lembessis P, Costa T, Tsipouras P, and Luyten FP (1997). Disruption of human limb morphogenesis by a dominant negative mutation in CDMP1. Nat Genet 17:58-64.
97. Tomkinson A, Reeve J, Shaw RW, and Noble BS (1997a). The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone. J Clin Endocrinol Metab 82: 3128-3135.
98. Tomkinson A, Gevers E, Wit JM, Reeve J, and Noble BS (1998). The role of estrogen in the control of rat osteocyte apoptosis. J Bone Miner Res 13:1243-1250.
99. Tondravi MM, McKercher SR, Anderson K, Erdmann JM, Quiroz M, Maki R, and Teitelbaum SL (1997). Osteopetrosis in mice lacking haematopoietic transcription factor PU.1. Nature 386:81-84.
100. Vortkamp A, Lee K, Lanske B, Segre GV, Kronenberg HM, and Tabin CJ (1996). Regulation of rate of cartilage differentiation by Indian Hedgehog and PTH-related protein. Science 273:613-622.
101. Wagner T, Wirth J, Meyer J, Zabel B, Held M, Zimmer J, Pasantes J, Bricarelli F, Keutel J, and Hustert E (1994). Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 79:1111-1120.
102. Wang Z-Q, Ovitt C, Grigoriadis AE, Mohle-Steinlein U, Ruther U and Wagner EF (1992). Bone and haematopoietic defects in mice lacking c-Fos. Nature 360:741-745.
103. Weir EC, Philbrick WM, Amling M, Neff LA, Baron R, and Broadus AE (1996). Targeted overexpression of parathyroid hormone-related peptide in chondrocytes causes chondrodysplasia and delayed endochondral bone formation. Proc Natl Acad Sci U S A 93:10240-10245.
104. Wong BR, Rho J, Arron J, Robinson E, Orlinick J, Chao M, Kalachikov S, Cayani E, Bartlett FS III, Frankel WN, Lee SY, and Choi Y (1997). TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J Biol Chem 272:25190-25194.
105. Wyllie AH, Kerr JFR, and Currie AR (1980). Cell death: The significance of apoptosis. Int Rev Cytol 68:251-306.
106. Xing L, Schwartzberg P, Reddy SV, Roodman GD, Mundy GR, Varmus HE, and Boyce BF (1996). Induction of osteoclast apoptosis in transgenic mice by a truncated SRC protein (Abstract). J Bone Miner Res 11:S140.
107. Xing L, Schwartzberg P, Sawyer T, Varmus HE, and Boyce BF (1997). Induction of osteoclast apoptosis in mutated src proteins and a src SH2 inhibitor (Abstract). J Bone Miner Res 12:S109.
108. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki SI, Tomoyasu K, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, and Suda T (1998a). Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A 95:3597-3602.
109. Yasuda H, Shima N, Nakagawa N, Mochizuki SI, Yano K, Fujise N, Sato Y, Goto M, Yamaguchi K, Kuriyama M, Kanno T, Murakami A, Tsuda E, Morinaga T, and Higashio K (1998b). Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 139: 1329-1337.
110. Yokouchi Y, Sakiyama J, KamedaT, Iba H, Suzuki A, Ueno N, and Kuroiwa A (1996). BMP-2/-4 mediate programmed cell death in chicken limb buds. Development 122:3725-3734.
111. Yoshida H, Hayashi S, Kunisada T, Ogawa M, Nishikawa S, Okamura H, Sudo T, Shultz LD, and Nishikawa S (1990). The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345:442-444.
112. Zou H and Niswander L (1996). Requirement for BMP signaling in interdigital apoptosis and scale formation. Science 272:738-741.
113. Zou H, Wieser R, Massague J, and Niswander L (1997). Distinct roles of type I bone morphogenetic protein receptors in the formation and differentiation of cartilage. Genes Dev 11:2191-2203.